Effect of desipramine on intestinal absorption of phenylbutazone and other drugs

S. Consolo, S. Garattini

Research output: Contribution to journalArticle

Abstract

Peak plasma phenylbutazone levels were reached 1-2 hr after the oral administration of phenylbutazone (40 mg/kg) to rats. Pretreatment with desipramine (DMI, 15 mg/kg) 1 hr before the oral administration of phenylbutazone resulted in a marked decrease in plasma phenylbutazone levels. Phenylbutazone and oxyphenylbutazone levels in 24 hr urine samples of DMI pretreated animals were lower than in controls. The stomach of DMI pretreated rats contained about 4 times more phenylbutazone than controls 4 hr after the oral administration of phenylbutazone while the values were similar after 14 hr. Intestinal contents of phenylbutazone were about 4 times higher in DMI pretreated animals even 14 hr after the oral administration of phenylbutazone. Pretreatment with DMI had no effect on the plasma levels of orally administered amphetamine (15 mg/kg) or pentobarbital (30 mg/kg) while plasma levels of orally administered oxyphenylbutazone (15 mg/kg), hydrocortisone (50 mg/kg) and salicylate (200 mg/kg) were lowered. The possibility that DMI inhibits the absorption of some orally administered drugs by relaxing gastro-intestinal smooth muscle is discussed.

Original languageEnglish
Pages (from-to)322-326
Number of pages5
JournalEuropean Journal of Pharmacology
Volume6
Issue number3
Publication statusPublished - Jun 1969

Fingerprint

Phenylbutazone
Desipramine
Intestinal Absorption
Pharmaceutical Preparations
Oral Administration
Oxyphenbutazone
Gastrointestinal Contents
Salicylates
Amphetamine
Pentobarbital
Smooth Muscle
Hydrocortisone
Stomach
Urine

Keywords

  • Absorption
  • Amphetamine
  • Desipramine
  • Hydrocortisone
  • Oxyphenylbutazone
  • Pentobarbital
  • Phenylbutazone
  • Plasma levels
  • Salicylate
  • Smooth muscle relaxation
  • Stomach levels
  • Urine levels

ASJC Scopus subject areas

  • Cellular and Molecular Neuroscience
  • Pharmacology

Cite this

Effect of desipramine on intestinal absorption of phenylbutazone and other drugs. / Consolo, S.; Garattini, S.

In: European Journal of Pharmacology, Vol. 6, No. 3, 06.1969, p. 322-326.

Research output: Contribution to journalArticle

@article{7260b404547648c2906370b244cbb004,
title = "Effect of desipramine on intestinal absorption of phenylbutazone and other drugs",
abstract = "Peak plasma phenylbutazone levels were reached 1-2 hr after the oral administration of phenylbutazone (40 mg/kg) to rats. Pretreatment with desipramine (DMI, 15 mg/kg) 1 hr before the oral administration of phenylbutazone resulted in a marked decrease in plasma phenylbutazone levels. Phenylbutazone and oxyphenylbutazone levels in 24 hr urine samples of DMI pretreated animals were lower than in controls. The stomach of DMI pretreated rats contained about 4 times more phenylbutazone than controls 4 hr after the oral administration of phenylbutazone while the values were similar after 14 hr. Intestinal contents of phenylbutazone were about 4 times higher in DMI pretreated animals even 14 hr after the oral administration of phenylbutazone. Pretreatment with DMI had no effect on the plasma levels of orally administered amphetamine (15 mg/kg) or pentobarbital (30 mg/kg) while plasma levels of orally administered oxyphenylbutazone (15 mg/kg), hydrocortisone (50 mg/kg) and salicylate (200 mg/kg) were lowered. The possibility that DMI inhibits the absorption of some orally administered drugs by relaxing gastro-intestinal smooth muscle is discussed.",
keywords = "Absorption, Amphetamine, Desipramine, Hydrocortisone, Oxyphenylbutazone, Pentobarbital, Phenylbutazone, Plasma levels, Salicylate, Smooth muscle relaxation, Stomach levels, Urine levels",
author = "S. Consolo and S. Garattini",
year = "1969",
month = "6",
language = "English",
volume = "6",
pages = "322--326",
journal = "European Journal of Pharmacology",
issn = "0014-2999",
publisher = "Elsevier",
number = "3",

}

TY - JOUR

T1 - Effect of desipramine on intestinal absorption of phenylbutazone and other drugs

AU - Consolo, S.

AU - Garattini, S.

PY - 1969/6

Y1 - 1969/6

N2 - Peak plasma phenylbutazone levels were reached 1-2 hr after the oral administration of phenylbutazone (40 mg/kg) to rats. Pretreatment with desipramine (DMI, 15 mg/kg) 1 hr before the oral administration of phenylbutazone resulted in a marked decrease in plasma phenylbutazone levels. Phenylbutazone and oxyphenylbutazone levels in 24 hr urine samples of DMI pretreated animals were lower than in controls. The stomach of DMI pretreated rats contained about 4 times more phenylbutazone than controls 4 hr after the oral administration of phenylbutazone while the values were similar after 14 hr. Intestinal contents of phenylbutazone were about 4 times higher in DMI pretreated animals even 14 hr after the oral administration of phenylbutazone. Pretreatment with DMI had no effect on the plasma levels of orally administered amphetamine (15 mg/kg) or pentobarbital (30 mg/kg) while plasma levels of orally administered oxyphenylbutazone (15 mg/kg), hydrocortisone (50 mg/kg) and salicylate (200 mg/kg) were lowered. The possibility that DMI inhibits the absorption of some orally administered drugs by relaxing gastro-intestinal smooth muscle is discussed.

AB - Peak plasma phenylbutazone levels were reached 1-2 hr after the oral administration of phenylbutazone (40 mg/kg) to rats. Pretreatment with desipramine (DMI, 15 mg/kg) 1 hr before the oral administration of phenylbutazone resulted in a marked decrease in plasma phenylbutazone levels. Phenylbutazone and oxyphenylbutazone levels in 24 hr urine samples of DMI pretreated animals were lower than in controls. The stomach of DMI pretreated rats contained about 4 times more phenylbutazone than controls 4 hr after the oral administration of phenylbutazone while the values were similar after 14 hr. Intestinal contents of phenylbutazone were about 4 times higher in DMI pretreated animals even 14 hr after the oral administration of phenylbutazone. Pretreatment with DMI had no effect on the plasma levels of orally administered amphetamine (15 mg/kg) or pentobarbital (30 mg/kg) while plasma levels of orally administered oxyphenylbutazone (15 mg/kg), hydrocortisone (50 mg/kg) and salicylate (200 mg/kg) were lowered. The possibility that DMI inhibits the absorption of some orally administered drugs by relaxing gastro-intestinal smooth muscle is discussed.

KW - Absorption

KW - Amphetamine

KW - Desipramine

KW - Hydrocortisone

KW - Oxyphenylbutazone

KW - Pentobarbital

KW - Phenylbutazone

KW - Plasma levels

KW - Salicylate

KW - Smooth muscle relaxation

KW - Stomach levels

KW - Urine levels

UR - http://www.scopus.com/inward/record.url?scp=0014450752&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0014450752&partnerID=8YFLogxK

M3 - Article

C2 - 5799193

AN - SCOPUS:0014450752

VL - 6

SP - 322

EP - 326

JO - European Journal of Pharmacology

JF - European Journal of Pharmacology

SN - 0014-2999

IS - 3

ER -